On (b)(6) 2017, abbott point of care was contacted by a customer regarding i-stat pt/inr cartridges that yielded unexpected results on a (b)(6) female patient being treated for dvt.There was no additional patient information available at the time of this report.Date of testing: (b)(6) 2017: i-stat: 7.2, acl top 500: 4.1.At the time of the event there was no indication of a product malfunction based on the information provided and assessed by apoc; however, this mdr is a retrospective filing in response to an observation from an fda inspection conducted (b)(4) 2017 at abbott point of care ((b)(4)).
|